{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T07:56:39Z","timestamp":1759564599536,"version":"3.44.0"},"reference-count":13,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,4,20]]},"abstract":"<jats:p>A woman in her late 40s presented with excessive per vagina (PV) bleeding and uterine fibroid. She reported excessive PV bleeding after starting Esmya; she was brought in by ambulance to the emergency department with profuse bleeding. Abnormal uterine bleeding (AUB) developed after selective progesterone receptor modulator (SPRM) administration in this symptomatic patient with uterine fibroid. The drug was withheld and surgical treatment considered. Progressive deterioration of PV bleeding after receiving SPRM led to an urgent <jats:italic>laparoscopic<\/jats:italic> total hysterectomy, which had to be postponed due to severe anaemia. Surgery took place regardless because the excessive bleeding continued. Histology revealed a 6\u2005cm submucosal uterine fibroid (SMUF) and adenomyosis. Physicians prescribing SPRMs to stop PV bleeding should be aware of potential AUB, which could lead to urgent hysterectomy. The mechanism of action of SPRMs is not clearly understood. Awareness of the side effects of Esmya, such as AUB, must be kept in mind when administering SPRMs.<\/jats:p>","DOI":"10.1136\/bcr-2014-209015","type":"journal-article","created":{"date-parts":[[2015,5,14]],"date-time":"2015-05-14T10:54:52Z","timestamp":1431600892000},"page":"bcr2014209015","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Abnormal excessive per vagina (PV) bleeding on Esmya\u2013selective progesterone receptor modulator (SPRM) in a symptomatic patient with uterine fibroid"],"prefix":"10.1136","volume":"2015","author":[{"given":"Lyubov","family":"Matytsina-Quinlan","sequence":"first","affiliation":[{"name":"ECCSH, MDGH, Macclesfield, Cheshire, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Matytsina","sequence":"additional","affiliation":[{"name":"Nevill Hall Hospital, Aneurin Bevan Health Board, Abergavenny, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,5,14]]},"reference":[{"key":"2025082701072482000_2015.may14_1.bcr2014209015.1","unstructured":"Electronic Medicines Compendium (ePC). Summary of product characteristics: Esmya 5\u2005mg tablets (ulipristal acetate) http:\/\/www.medicines.org.uk\/EMC\/medicine\/26068\/SPC\/2012 ."},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.2","unstructured":"The European Medicines Agency. Annex 1. Summary of product characteristics. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/002041\/WC500124085.pdf"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det467"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.4","doi-asserted-by":"publisher","DOI":"10.1111\/tog.12072"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.5","unstructured":"National Collaborating Centre for Women's and Children's Health. Commissioned by the National Institute for Health and Clinical Excellence (NICE). Heavy menstrual bleeding. London: RCOG Press, 2007."},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.6","doi-asserted-by":"publisher","DOI":"10.1783\/147118910791069178"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.7","doi-asserted-by":"crossref","unstructured":"Sarris I , Bewley S , Agnihotri S . Training in obstetrics and gynaecology. Oxford University Press, 2009.","DOI":"10.1093\/med\/9780199218479.001.0001"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.8","unstructured":"http:\/\/www.rcog.org.uk\/womens-health\/clinical-guidance\/pipelle-and-ultrasound-query-bank Pipelle and ultrasound\u2014query bank"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.9","doi-asserted-by":"crossref","unstructured":"FSRH Clinical Guidance. Contraception for women aged over 40\u2005years. London, 2010.","DOI":"10.12968\/indn.2010.15.7.77624"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.10","unstructured":"FSRH Clinical Guidance. Management of unscheduled bleeding in women using hormonal contraception. London, 2009."},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.11","doi-asserted-by":"crossref","first-page":"436174","DOI":"10.1155\/2012\/436174","article-title":"Effect of a selective progesterone receptor modulator on induction of apoptosis in uterine fibroids in vivo","volume":"2012","author":"Horak","year":"2012","journal-title":"Int J Endocrinol"},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.12","unstructured":"Faculty of Sexual and Reproductive Healthcare. Statement on drug interactions between hormonal contraception and ulipristal products: ellaOne\u00ae and Esmya \u00ae. London: Faculty of Sexual and Reproductive Health, 2012."},{"key":"2025082701072482000_2015.may14_1.bcr2014209015.13","first-page":"27","article-title":"Hystopatological correlation of adenomyosis and leomyoma in the hysterectomy specimen as cause of abnormal uterine bleeding in women different age group in the Kumaon region: a retrospective study","volume":"4","author":"Rizvi","year":"2013","journal-title":"J Midlife Health"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2014-209015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:07:34Z","timestamp":1756282054000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2014-209015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,14]]},"references-count":13,"alternative-id":["10.1136\/bcr-2014-209015"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2014-209015","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2015,5,14]]}}}